Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress
Yiji Liao(The University of Texas at San Antonio Health Science Center), Kexin Xu(The University of Texas at San Antonio Health Science Center), Bárbara de la Peña Avalos(The University of Texas at San Antonio Health Science Center), Shenglin Mei(Harvard University), Melissa Duarte(Dana-Farber Cancer Institute), Kornélia Polyák(Dana-Farber Cancer Institute), Eloïse Dray(The University of Texas MD Anderson Cancer Center), Tengfei Xiao(Lanzhou University), Myles Brown(Harvard University), X. Shirley Liu(Harbin Medical University), Jin Zhao(University of Chinese Academy of Sciences), Changmeng Cai(Center for Personalized Cancer Treatment), Philip W. Kantoff(Convergent Science (United States)), Henry W. Long(Dana-Farber Cancer Institute), Mei Yang(The University of Texas at San Antonio Health Science Center), Shuai Gao(New York Medical College), Pengya Xue(University of California, Berkeley), Avery Feit(Brigham and Women's Hospital), Steven P. Balk(Beth Israel Deaconess Medical Center), Roodolph St. Pierre(Broad Institute), Wei Li(Children's National), Ji Hoon Lee(Kunsan National University), Fei Teng(Tongji University), Zhijie Liu(The University of Texas at San Antonio Health Science Center), Han Xu(The University of Texas MD Anderson Cancer Center), Zhao Zhang(Nanjing Normal University), Neel Shah(Memorial Sloan Kettering Cancer Center), Chen-Hao Chen(Dana-Farber Cancer Institute), James E. Bradner(Novartis (China)), Shaokun Shu(Peking University)
Cited by 53
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
|New England Journal of Medicine|2010|5.5k
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k